Clinical Effect of Platelet Rich Plasma Combined With Laser on Scar
Clinical Study on Efficacy and Safety of Platelet Rich Plasma Combined With Laser for Scar Treatment
1 other identifier
interventional
29
1 country
1
Brief Summary
Investigation of Clinical Effect of Platelet Rich Plasma Combined With Laser on Acne Scar
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2013
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 9, 2015
CompletedFirst Posted
Study publicly available on registry
March 24, 2015
CompletedMarch 24, 2015
July 1, 2013
6 months
March 9, 2015
March 17, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Global assessment of acne scar
5-point grading of acne scar
12 weeks
Secondary Outcomes (2)
ECCA (échelle d'évaluation clinique des cicatrices d'acné)
12 weeks
adverse effect assessment
12 weeks
Study Arms (2)
fractional CO2 laser with PRP
EXPERIMENTALfractional carbon dioxide laser followed by intradermal injection of platelet rich plasma
fractional CO2 laser with NS
ACTIVE COMPARATORfractional carbon dioxide laser followed by intradermal injection of NS
Interventions
fractional carbon dioxide laser followed by platelet rich plasma injection
fractional carbon dioxide laser followed by normal saline injection
Eligibility Criteria
You may qualify if:
- moderate to severe acne scar
You may not qualify if:
- taken procedures for acne scar within 6 months
- underlying diabetes mellitus, keloid, or malignancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Dermatology, Seoul National University College of Medicine
Seoul, 110-744, South Korea
Related Publications (1)
Tierney EP, Eisen RF, Hanke CW. Fractionated CO2 laser skin rejuvenation. Dermatol Ther. 2011 Jan-Feb;24(1):41-53. doi: 10.1111/j.1529-8019.2010.01377.x.
PMID: 21276157BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Dae Hun Suh, PhD
Department of Dermatology, Seoul National University College of Medicine
- PRINCIPAL INVESTIGATOR
Seonguk Min, Msc
Department of Dermatology, Seoul National University College of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 9, 2015
First Posted
March 24, 2015
Study Start
March 1, 2013
Primary Completion
September 1, 2013
Study Completion
September 1, 2013
Last Updated
March 24, 2015
Record last verified: 2013-07